X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (9) 9
aged (6) 6
adult (5) 5
middle aged (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
female (4) 4
hematology, oncology and palliative medicine (4) 4
italy (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (4) 4
male (4) 4
treatment outcome (4) 4
adolescent (3) 3
chronic myelogenous leukemia (3) 3
clinical trials (3) 3
disease-free survival (3) 3
hematology (3) 3
kaplan-meier estimate (3) 3
leukemia (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - genetics (3) 3
oncology (3) 3
abridged index medicus (2) 2
aged, 80 and over (2) 2
analysis (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
benzamides (2) 2
dasatinib (2) 2
dexamethasone - adverse effects (2) 2
dosage and administration (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
imatinib mesylate (2) 2
interferon (2) 2
internal medicine (2) 2
maximum tolerated dose (2) 2
medicine, general & internal (2) 2
multiple myeloma (2) 2
neoplasm staging (2) 2
piperazines - therapeutic use (2) 2
product development (2) 2
prognosis (2) 2
prospective studies (2) 2
protein kinase inhibitors - therapeutic use (2) 2
pyrimidines - therapeutic use (2) 2
resistance (2) 2
studies (2) 2
thalidomide (2) 2
thalidomide - adverse effects (2) 2
transplantation, autologous (2) 2
abl tyrosine kinase (1) 1
acute lymphoblastic-leukemia (1) 1
administration, oral (1) 1
alpha (1) 1
alpha plus cytarabine (1) 1
angiogenesis (1) 1
antagonists (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antineoplastic antibiotics (1) 1
autologous transplantation (1) 1
bcr-abl (1) 1
bcr-abl1 transcript (1) 1
benzimidazoles - pharmacokinetics (1) 1
benzimidazoles - therapeutic use (1) 1
binding sites (1) 1
bms-354825 (1) 1
boronic acids - administration & dosage (1) 1
boronic acids - adverse effects (1) 1
bortezomib (1) 1
bosutinib (1) 1
busulfan (1) 1
cancer (1) 1
cardiovascular disease (1) 1
chemotherapy (1) 1
chemotherapy, adjuvant (1) 1
child (1) 1
chromosome-positive leukemias (1) 1
chromosomes (1) 1
chronic granulocytic-leukemia (1) 1
chronic myeloid leukaemia (1) 1
chronic-phase (1) 1
clinical medicine (1) 1
clinical-trial (1) 1
collection (1) 1
combination (1) 1
combination therapy (1) 1
combined modality therapy (1) 1
complications and side effects (1) 1
consolidation (1) 1
coronary vessels (1) 1
criteria (1) 1
cytogenetic response (1) 1
cytosine-arabinoside (1) 1
data collection (1) 1
design and construction (1) 1
development and progression (1) 1
dexamethasone (1) 1
dexamethasone - administration & dosage (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9758, pp. 2075 - 2085
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 612 - 621
Summary Background Ponatinib has shown potent activity against chronic myeloid leukaemia that is resistant to available treatment, although it is associated... 
Hematology, Oncology and Palliative Medicine | CHRONIC MYELOGENOUS LEUKEMIA | EARLY MOLECULAR RESPONSE | INTERFERON | ONCOLOGY | BOSUTINIB | RESISTANCE | TYROSINE KINASE INHIBITOR | FOLLOW-UP | DASATINIB | BCR-ABL1 TRANSCRIPT | NILOTINIB | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Imatinib Mesylate - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Imatinib Mesylate - administration & dosage | Pyridazines - administration & dosage | Aged, 80 and over | Adult | Female | Philadelphia Chromosome - drug effects | Pyridazines - adverse effects | Imidazoles - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Fusion Proteins, bcr-abl - genetics | Adolescent | Aged | Drug-Related Side Effects and Adverse Reactions - classification | Antimitotic agents | Clinical trials | Medical colleges | Product development | Research institutes | Antineoplastic agents | Analysis | Index Medicus | Life Sciences | Cancer
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 4, pp. 352 - 358
Journal Article
Journal Article
European Medical Journal Hematology, 08/2017, Volume 5, Issue 1, pp. 53 - 61
This symposium was dedicated to discussing BCR-ABL-positive chronic myeloid leukaemia (CML) and Philadelphia-positive acute lymphoblastic leukaemia (Ph+ALL).... 
tyrosine kinase inhibitors (TKI) | Philadelphia-positive acute lymphoblastic leukaemia (Ph+ALL) | Chronic myeloid leukaemia
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/1998, Volume 90, Issue 11, pp. 850 - 858
Background: Interferon alfa is a conservative and widely used alternative to bone marrow transplantation in treatment of patients with early chronic myeloid... 
CHRONIC MYELOGENOUS LEUKEMIA | CYTOSINE-ARABINOSIDE | CHRONIC GRANULOCYTIC-LEUKEMIA | MULTICENTER | CHRONIC-PHASE | ONCOLOGY | DISCRIMINATION | HYDROXYUREA | CYTOGENETIC RESPONSE | ALPHA | BUSULFAN | Medical research | Interferon | Drug therapy | Leukemia
Journal Article
Digestive and Liver Disease, ISSN 1590-8658, 2010, Volume 43, Issue 2, pp. 155 - 164
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.